Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-041335

10% owner sold 2,250,000 shares at $2.00 ($4,500,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BIOTIME INC 10% owner 2019-07-05 Sale −2,250,000 $2.00 $4,500,000 12,424,244 D
Open-market sales · 2,250,000 sh · avg $2.00 · $4,500,000
Loading xslF345X03/doc4.xml…